<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-01-22">January 22, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Enken</forename><surname>Gundlach</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">University Eye Hospital Charite</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Eye Center</orgName>
								<orgName type="institution">University Hospital Freiburg</orgName>
								<address>
									<settlement>Freiburg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><forename type="middle">Marcus</forename><surname>Hoffmann</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute for Clinical Chemistry and Laboratory Medicine</orgName>
								<orgName type="institution">University Hospital Freiburg</orgName>
								<address>
									<settlement>Freiburg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antje</forename><surname>Prasse</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Pneumology</orgName>
								<orgName type="institution">University Hospital Freiburg</orgName>
								<address>
									<settlement>Freiburg, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department Respiratory Medicine Medical School Hannover</orgName>
								<address>
									<settlement>Hannover, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Clinical Research Center Fraunhofer ITEM</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sonja</forename><surname>Heinzelmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Eye Center</orgName>
								<orgName type="institution">University Hospital Freiburg</orgName>
								<address>
									<settlement>Freiburg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Thomas</forename><surname>Ness</surname></persName>
							<email>thomas.ness@uniklinik-freiburg.de</email>
							<affiliation key="aff1">
								<orgName type="department">Eye Center</orgName>
								<orgName type="institution">University Hospital Freiburg</orgName>
								<address>
									<settlement>Freiburg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Oregon Health &amp; Science University</orgName>
								<address>
									<country key="US">UNITED STATES</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-01-22">January 22, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">609007CB7287D6E65A6E2E2AC7297335</idno>
					<idno type="DOI">10.1371/journal.pone.0147258</idno>
					<note type="submission">Received: July 18, 2015 Accepted: January 2, 2016 Funding: The authors have no support or funding to report.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>To study the impact of soluble IL2 receptor (sIL2R), chest x-ray (CxR), and angiotensin-converting enzyme (ACE) as markers for sarcoidosis in uveitis patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design</head><p><s>Retrospective study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Serum concentrations of sIL2R and ACE were measured in patients with active uveitis.</s><s>Those with elevated sIL2R and /or ACE values were examined for suspected systemic sarcoidosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Main Outcome Measure</head><p><s>Our main outcome parameters were the specificity and sensitivity of sIL2R, CxR and ACE in screening for ocular sarcoidosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>We measured 261 patients with uveitis for sarcoidosis using sIL2R and ACE between January 2008 and November 2011; sarcoidosis was been diagnosed using other tests (e.g. computer tomography, brochoalveolar lavage, biopsy) in 41 of 53 patients with elevated sIL2R values (&gt;639 U/ml</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Sarcoidosis or Morbus Boeck is a multisystem disorder of unknown cause <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>The organs involved are histologically characterized by non-caseating granulomas.</s><s>The organs most commonly affected are the mediastinal and hilar lymph nodes and the lungs (50-90%) <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Ophthalmic involvement occurs in 30-60% of patients with sarcoidosis <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s>In some cases sarcoidosis predominantly affects the eye.</s><s>According to the International Workshop of Ocular Sarcoidosis (IWOS) the term "ocular sarcoidosis" is used to describe such cases <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b9">10]</ref>.</s></p><p><s>Sarcoidosis is distributed worldwide and usually starts between the ages of 20 and 40 years.</s><s>Its prevalence in the USA is three times higher in the Afro-American population than in the Caucasian population <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16]</ref>.</s></p><p><s>Untreated sarcoidosis may be fatal, and intraocular involvement can lead to blindness <ref type="bibr" target="#b8">[9]</ref>.</s><s>The ophthalmologist's role is important, since uveitis may be the first manifestation of sarcoidosis <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19]</ref>.</s></p><p><s>However, diagnosing it can be challenging <ref type="bibr" target="#b19">[20]</ref>.</s><s>The gold standard is histopathological proof from biopsy tissue <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>As intraocular tissues are rarely biopsied due to the risk of vision loss, biopsies from nonocular tissues such as lung, skin and peripherial lymph nodes have been taken into account <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s>No other specific clinical symptom or investigation is diagnostic.</s><s>For this reason, and depending on the extent of work-up, sarcoidosis is probably under-diagnosed in uveitis patients.</s></p><p><s>In 2009, an international group of uveitis specialists therefore defined diagnostic criteria for ocular sarcoidosis, choosing criteria enabling the ophthalmologist to make the diagnosis of ocular sarcoidosis without the invasive diagnostic procedures needed for histological proof.</s><s>These criteria included signs of intraocular inflammation and laboratory investigations <ref type="bibr" target="#b6">[7]</ref>.</s></p><p><s>Not mentioned in these criteria is the soluble interleukin-2 receptor (sIL2R), a serum marker widely used for the diagnosis of and as an activity marker in pulmonary sarcoidosis <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30]</ref>.</s></p><p><s>Although its exact pathogenesis is unknown, sarcoidosis is characterized by T-cell activation <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s>Those activated T-cells express the interleukin-2 receptor on their surface (CD25, 55-kDa/75-kDaheterodimer) and release a soluble form of the 55-kDa chain called soluble IL2 receptor (sIL2R) <ref type="bibr" target="#b33">[34]</ref>.</s><s>The specific role of sIL2R in the immune response is not yet completely understood, but an elevated serum sIL2R level is known to correlate with the activity of T-cell-mediated diseases <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s>Such T-cell mediated diseases are systemic lupus erythematosus, juvenile idiopathic arthritis or sarcoidosis <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b37">38]</ref>.</s><s>The impact of sIL2R as a marker of disease activity in patients with systemic or pulmonary sarcoidosis has been shown in previous studies <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref>.</s><s>Soluble IL2-receptor is more sensitive than the serum marker ACE in detecting pulmonary sarcoidosis <ref type="bibr" target="#b40">[41]</ref>.</s><s>Further studies demonstrated that sIL2R might be useful both as a marker of severity and as a prognostic factor in systemic or pulmonary sarcoidosis <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref>.</s></p><p><s>The aim of this study was to evaluate the potential clinical usefulness of sIL2R as a screening parameter for sarcoidosis with uveitis in comparison to established markers (chest x-ray, ACE).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p><s>Between January 2008 and November 2011, 600 patients were seen with uveitis for the first time in the uveitis section at the Eye Center, University of Freiburg.</s><s>Out of these 261 were tested for sIL2R and ACE.</s><s>In 53 of those we detected elevated sIL2R.</s><s>All patients suspected of having intraocular sarcoidosis were referred to a respiratory specialist (pulmonologist).</s></p><p><s>Medical data were reviewed retrospectively.</s><s>We analyzed age, gender, comorbidity, current medications (including ACE inhibitors) and visual acuity.</s></p><p><s>Anatomical location of the uveitis and its severity were classified according to the standardisation in uveitis nomenclature (SUN) criteria <ref type="bibr" target="#b41">[42]</ref>.</s><s>In the absence of a real "gold standard", namely tissue biopsy from intraocular tissue, intraocular sarcoidosis was diagnosed according to recommended criteria from the International Workshop of Ocular Sarcoidosis (IWOS) <ref type="bibr" target="#b6">[7]</ref>.</s></p><p><s>We also collected chest radiographs, computer tomographies, bronchoalveolar lavage results, biopsies, and laboratory data.</s><s>In accordance with the European Respiratory Society patients with alveolar lymphocytes !</s><s>20% were considered to present a pathology <ref type="bibr" target="#b42">[43]</ref>.</s><s>Due to the study's being retrospective, these specific tests were not available for all patients.</s><s>An examination by an internal medicine specialist was also considered.</s></p><p><s>Institutional Review Board (IRB)/Ethics Committee approval was obtained (Ethik-Kommission der Albert-Ludwigs-Universität Freiburg (No.69/14)).</s><s>According to the IRB requirements patient records and information were anonymized and de-identified prior to analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of Serum Parameters</head><p><s>ACE levels were determined by spectrophotometric assay using the synthetic tripeptide substrate N-[3-(2-furyl)acryloyl]-L-phenylalanylglycylglycine (FAPGG), which is catalyzed by ACE to FAP and glycylglycine (Roche).</s><s>This hydrolysis results in a decrease in absorbance at 340 nm.</s></p><p><s>Soluble IL2R was measured via a solid-phase two-site chemiluminescence immunometric assay (Siemens, Germany).</s><s>Soluble IL2R in the sample binds to the solid-phase antibody and reagent antibody (coupled with alkaline phosphatase), forming a sandwich complex.</s><s>A chemiluminescent signal is generated in proportion to the bound enzyme.</s><s>According to the manufacturer, the threshold value for ACE is 82 U/mL and 639 U/ml for sIL2R, respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Contingency table to achieve specificity, sensitivity, positive predictive value and negative predictive value of ACE, chest x-ray and sIL2R were calculated using Prism from the Graph Pad.</s><s>The Youden Index, a marker of the performance of a diagnostic test, was also provided <ref type="bibr" target="#b43">[44]</ref>.</s><s>Furthermore, we compared sIL2R values between controls and sarcoidosis patients using the Wilcoxon-Mann-Whitney-test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient characteristics</head><p><s>The patients with elevated sIL2R were classified in two categories: the first included all patients with ocular sarcoidosis, including 41 patients with elevated sIL2R and one patient with normal sIL2R value (582 U/ml) and in the second, those with elevated sIL2R and no evidence of sarcoidosis.</s></p><p><s>The male/female ratio did not differ between these categories, and the median age was similar (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Due to the study being retrospective, sarcoidosis had been diagnosed in a variety of ways; the diagnosis of pulmonary sarcoidosis was confirmed by chest x-ray in 13 patients, by CT scan in 16 patients, by bronchoalveolar lavage in 18 patients <ref type="bibr" target="#b44">[45]</ref>, and by tissue biopsy in 10 patients, respectively.</s><s>Mean sIL2R value was 1310 U/ml (SEM ± 203; SD ± 1298) in the uveitis patients with sarcoidosis, while only 918 U/ml (SEM ± 89) in those uveitis patients without sarcoidosis but with elevated sIL2R (second group) (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Compared with all the uveitis patients (mean sIL2R = 414 U/ml; SEM ± 13, SD ± 180), the mean sIL2R value in sarcoidosis patients was significantly elevated (1310 U/ml) (p&lt;0.0001)</s><s>(Fig <ref type="figure" target="#fig_0">1a</ref>).</s></p><p><s>Mean ACE value was 59 U/ml in the sarcoidosis patients with uveitis (n = 41) while that of the uveitis patients without sarcoidosis (n = 220) was just 35 U/ml (Fig <ref type="figure" target="#fig_0">1b</ref>) (p&lt;0.001).</s><s>There are two patients in the ocular sarcoidosis group, and one patient in the no sarcoidosis group taking an ACE inhibitor.</s><s>Since in real life some uveitis patients will be taking ACE inhibitors during screening, we did not eliminate them from the calculation.</s><s>However, had we considered those patients in our analysis, it would have made no difference in our results.</s></p><p><s>The patients with elevated sIL2R/no sarcoidosis suffered from idiopathic non-granulomatous uveitis <ref type="bibr" target="#b5">(6)</ref>, from systemic autoimmune disease (3) (undifferentiated systemic autoimmune disease (2), lupus erythematosus (1)), mycoplasma infection (1), HLA B27 associated uveitis <ref type="bibr" target="#b0">(1)</ref> or TINU syndrome (tubulointerstitial nephritis and uveitis) (1).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sarcoidosis diagnosis</head><p><s>Based on results from the chest x-rays, CT scans, tissue biopsies and IWOS criteria, we detected 42 sarcoidosis patients with uveitis.</s><s>A diagnosis of definite ocular sarcoidosis was made in 10 patients, presumed ocular sarcoidosis in 12 patients, and probable ocular sarcoidosis in 19 patients.</s><s>One patient was diagnosed with possible ocular sarcoidosis (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>We classified these patients according to the SUN criteria.</s><s>Sixteen suffered from anterior uveitis, 8 from intermediate uveitis, 16 from posterior uveitis and two from panuveitis (Table <ref type="table" target="#tab_2">3</ref>).</s><s>Sensitivity, specificity, positive predictive value, negative predictive value, Youden Index Specificity was high for the chest x-ray, sIL2R and ACE.</s><s>It was lowest for sIL2R at 94%.</s><s>In contrast, the sIL2R sensitivity was 98%, chest x-ray 50%, and ACE only 22%.</s><s>Thus positive and negative predictive values were favorable for all factors, but Youden Index was only favorable for sIL2R (0,92) (Table <ref type="table" target="#tab_3">4</ref>, S1 Table <ref type="table">)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The eye is a potential primary and/or presenting site for the manifestation of sarcoidosis.</s><s>Ophthalmologists play a critical role in establishing its diagnosis <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b45">46]</ref>.</s><s>In 2009, an international group of uveitis specialists assessed diagnostic criteria for ocular sarcoidosis.</s><s>In addition to the clinical presentation and radiological signs, they also assessed laboratory results.</s><s>As predominant ocular sarcoidosis is rare, its clinical manifestation easily overlooked, and as current radiological findings and biopsy are invasive and often unavailable, a sensitive laboratory marker to screen for ocular sarcoidosis would be a substantial bonus.</s><s>Members of the international Workshop on Ocular Sarcoidosis recommended elevated serum angiotensin converting enzyme (ACE), elevated serum lysozyme and abnormal liver enzyme tests.</s><s>But none of those tests is highly sensitive <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b46">47]</ref>.</s></p><p><s>Serum angiotensin converting enzyme (ACE) is probably the most common laboratory test for sarcoidosis, revealing an approximate sensitivity of 57-73% and a specificity of 90% in the literature, but only 22% sensitivity and 90% specificity in our patients <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b48">49]</ref>.</s><s>Even in biopsyproven sarcoid uveitis cases, only 61.7% presented increased ACE values <ref type="bibr" target="#b49">[50]</ref>.</s></p><p><s>ACE is secreted by epithelioid cells and macrophages and is thus a marker for the general burden of granulomas <ref type="bibr" target="#b50">[51]</ref>.</s><s>ACE is indeed higher in clinically-active disease than in inactive disease, and it does correlate with the disease´s extent, but there is no correlation between initial ACE levels and the response to therapy or prognosis <ref type="bibr" target="#b51">[52]</ref>.</s><s>In addition, the ACE value should be interpreted with respect to the genotype <ref type="bibr" target="#b52">[53]</ref>.</s></p><p><s>An ideal marker would be one that is easy to obtain at any time and safe for the patient.</s><s>The serum sIL2R value fulfills these criteria and is already frequently used in the clinical routine for diagnosing pulmonary and systemic sarcoidosis <ref type="bibr" target="#b25">[26,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30]</ref>.</s><s>It is described as a marker of disease activity <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b53">54]</ref>.</s><s>Soluble IL2R is also known to be a marker for extrapulmonary involvement <ref type="bibr" target="#b53">[54,</ref><ref type="bibr" target="#b54">55]</ref>, its value as a disease marker in ocular sarcoidosis was first reported by our group in 2012, and confirmed by others later <ref type="bibr" target="#b55">[56,</ref><ref type="bibr" target="#b56">57]</ref>.</s></p><p><s>In the present retrospective study, we assessed serum sIL2R in a group of patients with ocular sarcoidosis.</s><s>On the basis of our data, we can claim that soluble IL-2R is a useful screening marker for sarcoidosis with uveitis.</s><s>All kinds of intraocular uveitis (anterior, intermediate, posterior, panuveitis) were detected as being associated with subclinical pulmonary sarcoidosis.</s><s>Furthermore, we measured a sensitivity of 22% and a specifity of 90% for ACE.</s><s>In direct comparison, IL2R seems to be the more appropriate screening tool for the diagnosis (sensitivity 98% // specificity 94%// Youden Index 92%).</s><s>Soluble IL2R is a parameter that indicates the extent of T-cell activation and has been known since the early eighties <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s>Elevated levels have therefore been measured in a variety of diseases such as systemic lupus erythematosus and juvenile idiopathic arthritis <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b37">38]</ref>.</s><s>Half of our 12 patients without sarcoidosis but elevated sIL2R values suffered from such diseases (e.g.</s><s>systemic autoimmune diseases).</s></p><p><s>An increased IL2R level has been reported to be associated with uveitis.</s><s>Few studies have demonstrated a relationship between sIL2R levels in peripheral blood and in aqueous humor with uveitis <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b58">59,</ref><ref type="bibr" target="#b59">60,</ref><ref type="bibr" target="#b60">61]</ref>.</s><s>Martin et al measured a mean sIL2R in the peripheral blood of 434 U/ml.</s><s>This value corresponds approximately to our mean in all the uveitis patients we tested (414 U/ml) <ref type="bibr" target="#b59">[60]</ref>.</s><s>Arocker-Mettinger et al also detected a slightly elevated sIL2R value in their patients <ref type="bibr" target="#b57">[58]</ref>.</s><s>There were, however, no sarcoidosis patients involved in either study, unfortunately.</s><s>Torun et al also noted elevated sIL2R values in their series of uveitis patients, but did not monitor them for sarcoidosis <ref type="bibr" target="#b61">[62]</ref>.</s><s>Papadaki et al recently negated any correlation between sIL2R and an associated autoimmune systemic disease <ref type="bibr" target="#b62">[63]</ref>, but they did report high sIL2R values in patients with sarcoidosis also.</s><s>Murray and Young found the highest levels in patients with sarcoidosis <ref type="bibr" target="#b60">[61]</ref>.</s></p><p><s>There are some limitations in our study; it is only a retrospective, single-center study.</s><s>As mentioned above, there is no real gold standard available, thus we applied the IWOS criteria.</s><s>Taking this into account, you will never even in a prospective study detect all true positives and false positives.</s><s>Therefore, there will be always some degree of uncertainity.</s></p><p><s>In addition, the performance of a test depends tremendously on the population in which it is assessed.</s><s>The specificity would be less in a population with lower incidence of sarcoidosis.</s></p><p><s>Nevertheless, our results clearly indicate that sIL2R levels are superior to ACE levels and CxR for identifying patients with sarcoidosis even if the study has the aforementioned limitations.</s></p><p><s>In summary: based on our data; we recommend adding the measurement of sIL2R in the routine diagnostic work-up of patients with uveitis as an additional screening parameter for intraocular sarcoidosis.</s><s>Moreover, already established biomarkers such as ACE and lysozyme may be replaced by sIL2R.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Soluble IL2R levels (a) (p &lt; 0.0001) and ACE levels (b) (p &lt; 0.001) for controls (all uveitis patients/no sarcoidosis) and sarcoidosis patients with uveitis (S1 Dataset).</s><s>doi:10.1371/journal.pone.0147258.g001</s></p></div></figDesc><graphic coords="5,36.00,78.01,449.75,507.80" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>[43]acteristics of patients with elevated sIL2R: gender, angiotensin converting enzyme (ACE), chest x-ray, high resolution CT scan, bronchoalveolar lavage (BAL) (pos BAL = !20%alveolar</s><s>lymphocytes[43]), tissue biopsy, Standard error of the mean (SEM).</s></p></div></figDesc><table><row><cell>Sarcoidosis* with uveitis</cell><cell>Uveitis without sarcoidosis*</cell></row><row><cell>n = 42</cell><cell>n = 12</cell></row></table><note><p><s>* according to the International Workshop of Ocular Sarcoidosis criteria (IWOS) doi:10.1371/journal.pone.0147258.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Number of patients according to the International Workshop of Ocular Sarcoidosis criteria (IWOS).</s></p></div></figDesc><table><row><cell>definite intraocular sarcoidosis</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>SUN classification of the sarcoidosis patients with uveitis (Number of patients).</s></p></div></figDesc><table><row><cell>sarcoidosis patients</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>[44]ingency tables: evaluation of sensitivity, specificity, positive predictive value (ppv), negative predictive value (npv) and Youden index[44]in screening for sarcoidosis with uveitis.</s></p></div></figDesc><table><row><cell></cell><cell>sensitivity</cell><cell>specificity</cell><cell>Youden Index</cell><cell>positive predictive value</cell><cell>negative predictive value</cell></row><row><cell>sIL2 R*</cell><cell>98%</cell><cell>94%</cell><cell>0.92</cell><cell>0.77</cell><cell>0.99</cell></row><row><cell>chest x-ray*</cell><cell>50%</cell><cell>100%</cell><cell>0.50</cell><cell>1.0</cell><cell>0.91</cell></row><row><cell>ACE*</cell><cell>22%</cell><cell>99.5%</cell><cell>0.22</cell><cell>0.9</cell><cell>0.87</cell></row><row><cell cols="4">* p&lt;0.0001; soluble Interleukin 2 Receptor (sIL2R); Angiotensin converting enzyme (ACE)</cell><cell></cell><cell></cell></row><row><cell cols="2">doi:10.1371/journal.pone.0147258.t004</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0147258January 22, 2016  </note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Extrapulmonary sarcoidosis. Semin Respir Crit Care Med</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Judson</surname></persName>
		</author>
		<idno type="DOI">10.1055/s-2007-970335</idno>
		<idno type="PMID">17330194</idno>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="83" to="101" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Ocular and neuro-ophthalmic manifestations of sarcoidosis: Retrospective study of 30 cases</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bezo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Majzoub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nochez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leruez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Charlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Milea</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jfo.2012.06.029</idno>
	</analytic>
	<monogr>
		<title level="j">J Fr Ophtalmol</title>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Lowder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Miserocchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Thorne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zierhut</surname></persName>
		</author>
		<author>
			<persName><surname>Sarcoid</surname></persName>
		</author>
		<idno type="DOI">10.3109/09273948.2014.941235</idno>
		<idno type="PMID">25014115</idno>
	</analytic>
	<monogr>
		<title level="j">Ocul Immunol Inflamm</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="253" to="256" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><surname>Sarcoidosis</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199704243361706</idno>
		<idno type="PMID">9110911</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">336</biblScope>
			<biblScope unit="page" from="1224" to="1234" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Rossman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Kreider</surname></persName>
		</author>
		<idno type="DOI">10.1513/pats.200607-138MS</idno>
		<idno type="PMID">17684288</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Am Thorac Soc</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="453" to="456" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Iannuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Rybicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Teirstein</surname></persName>
		</author>
		<author>
			<persName><surname>Sarcoidosis</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMra071714</idno>
		<idno type="PMID">18032765</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">357</biblScope>
			<biblScope unit="page" from="2153" to="2165" />
			<date type="published" when="2007">2007. NEJMra071714</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Herbort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mochizuki</surname></persName>
		</author>
		<idno type="DOI">10.1080/09273940902818861</idno>
		<idno type="PMID">19585358</idno>
	</analytic>
	<monogr>
		<title level="j">Ocul Immunol Inflamm</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="160" to="169" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Ocular involvement in sarcoidosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rothova</surname></persName>
		</author>
		<idno type="PMID">10611110</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="110" to="116" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Management of ocular sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Baughman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Lower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ingledue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Kaufman</surname></persName>
		</author>
		<idno type="PMID">23311120</idno>
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="26" to="33" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Controversy: ocular sarcoidosis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wakefield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zierhut</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="5" to="9" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Birnbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chakrabarti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Tessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Goldstein</surname></persName>
		</author>
		<idno type="DOI">10.1001/archophthalmol.2011.52</idno>
		<idno type="PMID">21482866</idno>
	</analytic>
	<monogr>
		<title level="j">Arch Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="409" to="413" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Epidemiology of sarcoidosis in the U.S. Navy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Sartwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Edwards</surname></persName>
		</author>
		<idno type="PMID">4818715</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="250" to="257" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Concepts of epidemiology of sarcoidosis; preliminary report of 1,194 cases reviewed with special reference to geographic ecology</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Cummings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dunner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Schmidt</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Barnwell</surname></persName>
		</author>
		<idno type="PMID">13322744</idno>
	</analytic>
	<monogr>
		<title level="j">Postgrad Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="437" to="446" />
			<date type="published" when="1956">1956</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Sarcoidosis in the United States Navy</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Gundelfinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Britten</surname></persName>
		</author>
		<idno type="PMID">13902941</idno>
	</analytic>
	<monogr>
		<title level="j">Am Rev Respir Dis</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="109" to="115" />
			<date type="published" when="1961">1961</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Sarcoidosis; a clinicopathologic review of 300 cases, including 22 autopsies</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ricker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Clark</surname></persName>
		</author>
		<idno type="PMID">18135500</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="725" to="749" />
			<date type="published" when="1949">1949</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Labree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Rao</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ophtha.2006.05.074</idno>
		<idno type="PMID">17123620</idno>
	</analytic>
	<monogr>
		<title level="j">Ophthalmology</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="325" to="333" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Guidelines for the management of uveitis in internal medicine</title>
		<author>
			<persName><forename type="first">S</forename><surname>Abad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dhote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Brezin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.revmed.2008.08.011</idno>
		<idno type="PMID">18824279</idno>
	</analytic>
	<monogr>
		<title level="j">Rev Med Interne</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="492" to="500" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Choroidal white lesions as an early manifestation of sarcoidosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Thorne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Brucker</surname></persName>
		</author>
		<idno type="PMID">10696740</idno>
	</analytic>
	<monogr>
		<title level="j">Retina</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="8" to="15" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Uveitis as initial manifestation of sarcoidosis: study of 31 patients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Adan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Llobet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Segura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marieges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Casaroli-Marano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="PMID">15171910</idno>
	</analytic>
	<monogr>
		<title level="j">Med Clin Barc</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="748" to="752" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Sarcoid uveitis: Diagnostic and therapeutic update</title>
		<author>
			<persName><forename type="first">L</forename><surname>Varron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kodjikian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seve</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.revmed.2010.09.003</idno>
		<idno type="PMID">20970226</idno>
	</analytic>
	<monogr>
		<title level="j">Rev Med Interne</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="86" to="92" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A concise review of pulmonary sarcoidosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Baughman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Culver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Judson</forename><forename type="middle">Ma</forename></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201006-0865CI</idno>
		<idno type="PMID">21037016</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="573" to="581" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Diagnostic criteria for sarcoidosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Heinle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.autrev.2014.01.035</idno>
		<idno type="PMID">24424172</idno>
	</analytic>
	<monogr>
		<title level="j">Autoimmun Rev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="383" to="387" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hanada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Horie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sugamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sugita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mochizuki</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10384-006-0413-2</idno>
		<idno type="PMID">17401622</idno>
	</analytic>
	<monogr>
		<title level="j">Jpn J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="121" to="126" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">TNFalpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Ziegenhagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">K</forename><surname>Benner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schlaak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Quernheim</surname></persName>
		</author>
		<author>
			<persName><surname>Sarcoidosis</surname></persName>
		</author>
		<idno type="PMID">9372680</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="1586" to="1592" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Ziegenhagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Rothe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schlaak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Quernheim</surname></persName>
		</author>
		<idno type="PMID">12661993</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="407" to="413" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Conventional markers in determination of activity of sarcoidosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gungor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ozseker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yalcinsoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Akkaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Can</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Eroglu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.intimp.2015.01.015</idno>
		<idno type="PMID">25623898</idno>
	</analytic>
	<monogr>
		<title level="j">Int Immunopharmacol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="174" to="179" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Modulatory effects of proinflammatory cytokines for action cascading processes-evidence from neurosarcoidosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Beste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kneiphof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Woitalla</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbi.2014.05.005</idno>
		<idno type="PMID">24846477</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Behav Immun</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="126" to="133" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis</title>
		<author>
			<persName><forename type="first">Rlm</forename><surname>Mostard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Smj</forename><surname>Van Kuijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Verschakelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mjpg</forename><surname>Van Kroonenburgh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Nelemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pahm</forename><surname>Wijnen</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2466-12-57</idno>
		<idno type="PMID">22978780</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Pulm Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">57</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis</title>
		<author>
			<persName><forename type="first">H-F</forename><surname>Petereit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Reske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tumani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jarius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Markus</forename><surname>Leweke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Woitalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1007/s00415-010-5623-3</idno>
		<idno type="PMID">20556411</idno>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">257</biblScope>
			<biblScope unit="page" from="1855" to="1863" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Comparative evaluation of serum markers in pulmonary sarcoidosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Miyoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kadowaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Irifune</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.09-1975</idno>
		<idno type="PMID">20081103</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="1391" to="1397" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Authier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Chazaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Christov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cherin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Barlovatz-Meimon</surname></persName>
		</author>
		<idno type="PMID">9160898</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropathol Appl Neurobiol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="132" to="140" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Teschler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hubner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Striz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Costabel</surname></persName>
		</author>
		<idno type="PMID">7663784</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="1061" to="1066" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Uyttenhove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wauters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Snick</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.1830200102</idno>
		<idno type="PMID">2407536</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note>Accessory factors involved in murine T cell activation</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Theze</surname></persName>
		</author>
		<idno type="PMID">3119713</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="3680" to="3684" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Campen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Horwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Quismorio</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Ehresmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Martin</surname></persName>
		</author>
		<idno type="PMID">3263865</idno>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1358" to="1364" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Serum markers of T cell activation in relapses of Wegener&apos;s granulomatosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Stegeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Tervaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Huitema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Kallenberg</surname></persName>
		</author>
		<idno type="PMID">8443965</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="415" to="420" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Wigfall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Sakai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Jordan</surname></persName>
		</author>
		<idno type="PMID">3131053</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol Immunopathol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="354" to="362" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mangge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kenzian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gallistl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Neuwirth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liebmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kaulfersch</surname></persName>
		</author>
		<idno type="PMID">7848311</idno>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="211" to="220" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Brousseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kurman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marcon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Nelson</surname></persName>
		</author>
		<idno type="PMID">3128148</idno>
	</analytic>
	<monogr>
		<title level="j">Am Rev Respir Dis</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="759" to="764" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Quernheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pfeifer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Strausz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ferlinz</surname></persName>
		</author>
		<idno type="PMID">1741545</idno>
	</analytic>
	<monogr>
		<title level="j">Am Rev Respir Dis</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="1322" to="1329" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">ACE serum level and correlation to the clinical course of sarcoidosis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Uhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Steppling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lorenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Schulz</surname></persName>
		</author>
		<idno type="PMID">6316312</idno>
	</analytic>
	<monogr>
		<title level="j">Prax Klin Pneumol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="553" to="556" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Jabs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Nussenblatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Rosenbaum</surname></persName>
		</author>
		<idno type="PMID">16196117</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="509" to="516" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Hunninghake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Costabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baughman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Cordier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bois</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG World Assoc Sarcoidosis Granulomatous Disord</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="149" to="173" />
			<date type="published" when="1999">1999</date>
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
	<note>ATS/ERS/WASOG statement on sarcoidosis</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Index for rating diagnostic tests</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Youden</surname></persName>
		</author>
		<idno type="PMID">15405679</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="32" to="35" />
			<date type="published" when="1950">1950</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Broncho-alveolar lavage (BAL) for the diagnosis of sarcoidosic uveitis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Caspers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ebraert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Makhoul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Willermain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Michel</surname></persName>
		</author>
		<idno type="DOI">10.3109/09273948.2013.820836</idno>
		<idno type="PMID">24063526</idno>
	</analytic>
	<monogr>
		<title level="j">Ocul Immunol Inflamm</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="102" to="109" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">The Eye as a Common Site for the Early Clinical Manifestation of Sarcoidosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Heiligenhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wefelmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wefelmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schrenk</surname></persName>
		</author>
		<idno type="DOI">10.1159/000321947</idno>
		<idno type="PMID">21099232</idno>
	</analytic>
	<monogr>
		<title level="j">Ophthalmic Res</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="9" to="12" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Liver-test abnormalities in sarcoidosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cremers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Drent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Driessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nieman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wijnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baughman</surname></persName>
		</author>
		<idno type="DOI">10.1097/MEG.0b013e32834c7b71</idno>
		<idno type="PMID">22008629</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="17" to="24" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Serum angiotensin converting enzyme in sarcoidosis-its value in present clinical practice</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Studdy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bird</surname></persName>
		</author>
		<idno type="PMID">2544134</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Clin Biochem</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="13" to="18" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note>Pt 1</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Power</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Neves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pedroza-Seres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Foster</surname></persName>
		</author>
		<idno type="PMID">9098308</idno>
	</analytic>
	<monogr>
		<title level="j">Ophthalmology</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="2007" to="2011" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Clinical features and diagnostic evaluation of 83 biopsy-proven sarcoid uveitis cases</title>
		<author>
			<persName><forename type="first">C</forename><surname>Febvay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kodjikian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Maucort-Boulch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Perard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Iwaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jamilloux</surname></persName>
		</author>
		<idno type="DOI">10.1136/bjophthalmol-2014-306353</idno>
		<idno>doi: 10.1136/ bjophthalmol-2014-306353</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Steinbrech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Landas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Hunninghake</surname></persName>
		</author>
		<idno type="PMID">8393640</idno>
	</analytic>
	<monogr>
		<title level="j">Am Rev Respir Dis</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="483" to="486" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Baughman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Bosken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mantil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hurtubise</surname></persName>
		</author>
		<idno type="PMID">6326626</idno>
	</analytic>
	<monogr>
		<title level="j">Am Rev Respir Dis</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="676" to="681" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Biller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ruprecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Gaede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Quernheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zissel</surname></persName>
		</author>
		<idno type="PMID">20560294</idno>
	</analytic>
	<monogr>
		<title level="j">Sarcoidosis Vasc Diffuse Lung Dis</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="139" to="146" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Phenotyping sarcoidosis from a pulmonary perspective</title>
		<author>
			<persName><forename type="first">A</forename><surname>Prasse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Katic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Germann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Buchwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Quernheim</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.200705-742OC</idno>
		<idno type="PMID">17975200</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="330" to="336" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Grutters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Fellrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mulder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Van Den Bosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Velzen-Blad</surname></persName>
		</author>
		<idno type="PMID">12853522</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="186" to="195" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<title level="m" type="main">Soluble Interleukin 2 Receptor, Angiotensin Converting Enzyme, And Neopterin in Screening Ocular Sarcoidosis And Monitoring Disease Activity</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Boehringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heinzelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gundlach</surname></persName>
		</author>
		<ptr target="http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=4642eb33-585a-4144-b19a-2441768ee67b&amp;cKey=6b18ab40-1a2b-4381-86c8-70fc743b0b16&amp;mKey=f0fce029-9bf8-4e7c-b48e-9ff7711d4a0e" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Predictive value of serum markers for pulmonary involvement in ocular sarcoidosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Grajewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arfaoui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Schlereth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kirchhof</surname></persName>
		</author>
		<idno type="DOI">10.1111/aos.12248</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Ophthalmol (Copenh)</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="e250" to="251" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Serum interleukin 2-receptor levels in uveitis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Arocker-Mettinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Asenbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ulbrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grabner</surname></persName>
		</author>
		<idno type="PMID">2384010</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Eye Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="25" to="29" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Serum levels of interleukin-2 receptor in ocular Behcet&apos;s disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Benezra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maftzir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kalichman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Barak</surname></persName>
		</author>
		<idno type="PMID">8420374</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="26" to="30" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Lacomba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Molina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Chamond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Galera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Estevez</surname></persName>
		</author>
		<idno type="PMID">10806443</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Eye Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="287" to="292" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Soluble interleukin-2 receptors in retinal vasculitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Young</surname></persName>
		</author>
		<idno type="PMID">1424745</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Eye Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="193" to="195" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Serum cytokine receptor levels in noninfectious uveitis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Torun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Callizo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Orlic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Pleyer</surname></persName>
		</author>
		<idno type="DOI">10.1159/000084271</idno>
		<idno type="PMID">15746567</idno>
	</analytic>
	<monogr>
		<title level="j">Ophthalmic Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="112" to="116" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Serum soluble interleukin-2 receptor levels do not correlate with an associated systemic disease in patients with uveitis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Papadaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Iaccheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fiore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Zacharopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thadani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Christen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1755-3768.2008.01422.x</idno>
		<idno type="PMID">19493254</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="e28" to="29" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
